Who are Cefuroxime Axetil Dispersible Tablets's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): CEPHALEXIN, Imipenem/Cilastatin/Relebactam, I.V cefuroxime 750 mg*3/d for 2 days, amoxicillin/clavulanate potassium 1gm, Cefepime, Meropenem, or Piperacillin/Tazobactam, I.V ampicillin 2 gram x4/d for 2 days.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/cefuroxime-axetil-dispersible-tablets.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Cefuroxime Axetil Dispersible Tablets — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cefuroxime Axetil Dispersible Tablets (Cefuroxime Axetil Dispersible Tablets) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Cephalosporin antibiotic. Area: Infectious Disease.

phase 2 Cephalosporin antibiotic Penicillin-binding proteins Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Cefuroxime Axetil Dispersible Tablets (Cefuroxime Axetil Dispersible Tablets) — Jiangsu Famous Medical Technology Co., Ltd.. Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Cefuroxime Axetil Dispersible Tablets TARGET	Cefuroxime Axetil Dispersible Tablets	Jiangsu Famous Medical Technology Co., Ltd.	phase 2	Cephalosporin antibiotic	Penicillin-binding proteins
CEPHALEXIN	CEPHALEXIN		marketed	First-generation cephalosporin	Penicillin-binding proteins (PBPs)	1971-01-01
Imipenem/Cilastatin/Relebactam	Imipenem/Cilastatin/Relebactam	Evopoint Biosciences Inc.	marketed	Carbapenem antibiotic with beta-lactamase inhibitor	Bacterial penicillin-binding proteins; serine beta-lactamases
*I.V cefuroxime 750 mg3/d for 2 days**	I.V cefuroxime 750 mg*3/d for 2 days	Western Galilee Hospital-Nahariya	marketed	Second-generation cephalosporin	Penicillin-binding proteins (PBPs)
amoxicillin/clavulanate potassium 1gm	amoxicillin/clavulanate potassium 1gm	GlaxoSmithKline	marketed	Beta-lactam antibiotic with beta-lactamase inhibitor	Penicillin-binding proteins (PBPs); bacterial beta-lactamase
Cefepime, Meropenem, or Piperacillin/Tazobactam	Cefepime, Meropenem, or Piperacillin/Tazobactam	University of Florida	marketed	Beta-lactam antibiotic (cephalosporin, carbapenem, or aminopenicillin with beta-lactamase inhibitor)	Penicillin-binding proteins (PBPs); bacterial cell wall peptidoglycan
I.V ampicillin 2 gram x4/d for 2 days	I.V ampicillin 2 gram x4/d for 2 days	Western Galilee Hospital-Nahariya	marketed	Beta-lactam antibiotic (aminopenicillin)	Penicillin-binding proteins (PBPs); bacterial peptidoglycan

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Cephalosporin antibiotic class)

Hospital de Clinicas de Porto Alegre · 2 drugs in this class
Ain Shams Maternity Hospital · 1 drug in this class
Arrevus Inc. · 1 drug in this class
Jiangsu Famous Medical Technology Co., Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Cefuroxime Axetil Dispersible Tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/cefuroxime-axetil-dispersible-tablets. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab